TAVR May Be A Good Choice For Even Low-Risk Patients, NOTION Trial Shows
This article was originally published in The Gray Sheet
Executive Summary
So far, transcatheter aortic valves are only indicated for patients for whom surgery presents high or even intolerable risks. Two-year data from a trial in Scandinavia suggests TAVR could eventually supplant surgical valve replacement in patients at low risk during surgery, but this approach will require more study.